<!- -> Image credit: Shutterstock Avacta Group has acquired Coris BioConcept for £7.4 million ($9.2 million) with an earnout based on future business performance, payable in cash, of up to £3 million. Coris BioConcept, based in Belgium and established in 1996, manufactures and markets a variety of lateral flow tests for use in the healthcare [...]
Coris BioConcept is a Germany-based medical device company that manufactures and markets rapid diagnostic test kits for the detection of human infectious pathogens.